Evidence map›Paper›PMID 41089458›Full record

ArticleThe journal of allergy and clinical immunology. Global2025

Idiopathic hypereosinophilic syndrome: Potential pathologic somatic gene variants identified by exome sequencing.

Alejandro Ferrer, Mrunal Dehankar, Saurabh Baheti, Mrinal M Patnaik, Thanai Pongdee

Abstract read
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alejandro FerrerDivision of Hematology, Mayo Clinic, Rochester, Minn.
Mrunal DehankarDivision of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minn.
Saurabh BahetiDivision of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minn.
Mrinal M PatnaikDivision of Hematology, Mayo Clinic, Rochester, Minn.
Thanai PongdeeDivision of Hematology, Mayo Clinic, Rochester, Minn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hypereosinophilic syndrome (HES) is a rare group of disorders characterized by eosinophilia in blood and/or tissues. The etiology of HES is largely unknown. Characterizing the molecular pathophysiology of HES may improve diagnostic and therapeutic methodology. Objective: We sought to identify somatic gene variants associated with idiopathic HES using exome sequencing. Methods: Exome sequencing (SureSelect capture kit, 80× average depth) was performed using either PBMCs or bone marrow cytogenetic pellets from 31 patients with idiopathic HES. We used Mutect2 in tumor-only mode with gnomAD as the germline resource and FilterMutectCalls for confident somatic variant calling. Variants selected had at least 20 supporting reads, variant allele frequency below 35%, high Clinical Annotation of Variants impact, and minor allele frequency of <1% in gnomAD and Mayo Clinic Biobank. Results: A total of 332 unique variants in 310 genes were identified at least in 1 patient. Of these, 5 genes were found recurrently mutated (present in at least 10% of samples): Conclusions: Several somatic mutations were identified in our cohort of patients with idiopathic HES. Increasing the number of patients through collaborative efforts and pursuing functional testing of these variants will help elucidate the importance of these genes in idiopathic HES.

Indexed as

Eosinophilgenehypereosinophilic syndromesequencingvariant

Identifiers

PMID41089458
PMCPMC12516552

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.